(Q38293754)

1 September 2017

title

Mutational analysis of the beta-tubulin gene in lung cancer (English)

1 reference

1 September 2017

1 reference

1 reference

7

Shigeru Kohno

1 reference

1 September 2017

Junji Tsurutani

1

1 reference

1 September 2017

Takefumi Komiya

2

1 reference

1 September 2017

Hisao Uejima

3

1 reference

1 September 2017

Hirohito Tada

4

1 reference

1 September 2017

Negoro Syunichi

5

1 reference

1 September 2017

Mikio Oka

6

1 reference

1 September 2017

Masahiro Fukuoka

8

1 reference

1 September 2017

Kazuhiko Nakagawa

9

1 reference

1 September 2017

publication date

1 January 2002

1 reference

1 September 2017

1 reference

1 September 2017

volume

35

1 reference

1 September 2017

issue

1

1 reference

1 September 2017

page(s)

11-16

1 reference

Charles F. Kettering Prize. P-glycoprotein and resistance to anticancer drugs

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900291-4

7 January 2021

CHO mutants resistant to colchicine, colcemid or griseofulvin have an altered beta-tubulin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900291-4

7 January 2021

A beta-tubulin leucine cluster involved in microtubule assembly and paclitaxel resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900291-4

7 January 2021

Taxol-dependent mutants of Chinese hamster ovary cells with alterations in alpha- and beta-tubulin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900291-4

7 January 2021

Paclitaxel resistance in non-small-cell lung cancer associated with beta-tubulin gene mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900291-4

7 January 2021

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900291-4

7 January 2021

Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900291-4

7 January 2021

Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900291-4

7 January 2021

Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900291-4

7 January 2021

Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900291-4

7 January 2021

K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900291-4

7 January 2021

Diverse Mechanisms in the Generation of Human β-Tubulin Pseudogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900291-4

7 January 2021

Evidence that a human beta-tubulin pseudogene is derived from its corresponding mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900291-4

7 January 2021

Identification of two human beta-tubulin isotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900291-4

7 January 2021

Evolutionary history of a multigene family: an expressed human beta-tubulin gene and three processed pseudogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900291-4

7 January 2021

Antisense oligonucleotides to class III beta-tubulin sensitize drug-resistant cells to Taxol

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900291-4

7 January 2021

Preferential binding of E7010 to murine beta 3-tubulin and decreased beta 3-tubulin in E7010-resistant cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900291-4

7 January 2021

Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell Lines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900291-4

7 January 2021

Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900291-4

7 January 2021

The direct activation of human multidrug resistance gene (MDR1) by anticancer agents

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900291-4

7 January 2021

10.1016/S0169-5002(01)00291-4

Identifiers

DOI

1 reference

1 September 2017

1 reference